Related Experiment Videos
Molecular biology of bladder cancer
R N Borland1, C B Brendler, W B Isaacs
1Department of Urology, Johns Hopkins Hospital, Baltimore, Maryland.
Abstract:
Recent studies have provided the first clues as to the molecular mechanisms responsible for bladder carcinogenesis. Cytogenetic and molecular studies have demonstrated nonrandom changes of chromosomes 1, 5, 7, 9, 11, and 17. The finding of monosomy of chromosome 9 in early noninvasive lesions has initiated a search for a bladder-specific gene responsible for bladder oncogenesis. Activation of ras and erbB oncogenes has been reported, although the role that these changes play in bladder cancer is not yet understood. Inactivation of two well-characterized tumor suppressor genes, p53 and Rb, also appears to be important in the pathogenesis of bladder cancer, and evidence suggests that inactivation of p53 correlates with the acquisition by bladder cancer cells of the invasive phenotype. Although the picture is far from complete, it is clear that for the first time an understanding of the molecular events responsible for bladder cancer is possible, and that this information will have clinical impact on patients in the near future.
Insights
Researchers are uncovering the molecular basis of bladder cancer, identifying key genetic changes like chromosome alterations and tumor suppressor gene inactivation. This growing understanding of bladder carcinogenesis promises future clinical applications for patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Bladder cancer development involves complex molecular mechanisms.
- Previous research hinted at genetic alterations but lacked comprehensive understanding.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying bladder carcinogenesis.
- To identify key genetic alterations associated with bladder cancer progression.
Main Methods:
- Cytogenetic analysis of chromosomes.
- Molecular studies investigating oncogenes and tumor suppressor genes.
Main Results:
- Identified nonrandom chromosomal changes in chromosomes 1, 5, 7, 9, 11, and 17.
- Observed monosomy of chromosome 9 in early lesions, suggesting a potential bladder-specific oncogene.
- Reported activation of ras and erbB oncogenes.
- Found inactivation of tumor suppressor genes p53 and Rb, with p53 inactivation correlating with invasive bladder cancer.
Conclusions:
- The molecular events driving bladder cancer are becoming clearer.
- Understanding these genetic changes is crucial for future clinical impact in bladder cancer treatment.